5th MENA Congress for Rare Diseases 2026
The 5th MENA Congress for Rare Diseases 2026 will take place from…
The Emirates Drug Foundation approves gene therapy for gene replacement in a new age group of spinal muscular atrophy patients.
 The Emirates Drug Authority (EDA) has announced the approval of Itvisma, a…
Pediatric Leukemia Breakthroughs: Genetics & Care | Dr. Jack Bartram | EPHOC
Dr. Jack Bartram, a consultant pediatric hematologist from Great Ormond Street Hospital…
Emirates Pediatric BMT & Gene Therapy Congress Take Center Stage in Abu Dhabi This November 8-9
This November 8-9, Abu Dhabi hosts a global gathering of pioneers in…
Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO®
Boehringer Ingelheim and LEO Pharma today announced an exclusive global license and…
Sanofi Completes Acquisition of Blueprint Medicines
Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint),…
Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
‘‘We Are Shifting From A Reactive To Preventive Approach In Healthcare’’ – Pelin Incesu
AstraZeneca is making a significant impact in the Middle East and Africa…
‘‘Embracing Digital Health Solutions Is A Critical Priority’’
Leading the industry’s top healthcare company and becoming the first female CEO…
MENA Congress for Rare Diseases 2025
MENA Congress for Rare Diseases 2025 in partnership with Burjeel Medical City…
